Leo TM van der Ven

Dr. Leo TM van der Ven

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
FBFrançois Busquet
François Busquet
RSRuben Strecker
Ruben Strecker
JRJane M. Rawlings
Jane M. Rawlings
SBScott E. Belanger
Scott E. Belanger
TBThomas Braunbeck
Thomas Braunbeck
MHMarlies Halder
Marlies Halder
The OECD validation study of the zebrafish embryo acute toxicity test (ZFET) for acute aquatic toxicity testing evaluated the ZFET reproducibility by testing 20 chemicals at 5 different concentrations in 3 independent runs in at least 3 laboratories. Stock solutions and test concentrations were analytically confirmed for 11 chemicals. Newly fertilised zebrafish eggs (20/concentration and control) were exposed for 96h to chemicals. Four apical endpoints were recorded daily as indicators of acute lethality: coagulation of the embryo, lack of somite formation, non-detachment of the tail bud from the yolk sac and lack of heartbeat. Results (LC50 values for 48/96h exposure) show that the ZFET is a robust method with a good intra- and inter-laboratory reproducibility (CV30%) for some very toxic or volatile chemicals, and chemicals tested close to their limit of solubility. The ZFET is now available as OECD Test Guideline 236. Considering the high predictive capacity of the ZFET demonstrated by Belanger et al. (2013) in their retrospective analysis of acute fish toxicity and fish embryo acute toxicity data, the ZFET is ready to be considered for acute fish toxicity for regulatory purposes.

1 July 2014 in Toxicology
Verified
Journal Article
Closed access
JEJ.C.J. van Esterik
J.C.J. van Esterik
MDMartijn E.T. Dollé
Martijn E.T. Dollé
MLM.H. Lamoree
M.H. Lamoree
SLS.P.J. van Leeuwen
S.P.J. van Leeuwen
THT. Hamers
T. Hamers
LVLeo TM van der Ven
Leo TM van der Ven

6 April 2013 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
MDMarja Driessen
Marja Driessen
AKAnne S. Kienhuis
Anne S. Kienhuis
JPJeroen L. A. Pennings
Jeroen L. A. Pennings
TPTessa Pronk
Tessa Pronk
EBEvert-Jan van de Brandhof
Evert-Jan van de Brandhof
LVLeo TM van der Ven
Leo TM van der Ven

1 March 2008 in Toxicology
Verified
Journal Article
Closed access
LVLeo TM van der Ven
Leo TM van der Ven
TKTon van de Kuil
Ton van de Kuil
AVAart Verhoef
Aart Verhoef
PLPim E.G. Leonards
Pim E.G. Leonards
WSWout Slob
Wout Slob
JVJosephus G. Vos
Josephus G. Vos

1 January 2014 in Particle and Fibre Toxicology
Verified
Journal Article
Open access
PDF file
Rob VandebrielRob Vandebriel
Rob Vandebriel
ETElisa Cm Tonk
Elisa Cm Tonk
LFLiset J de la Fonteyne-Blankestijn
Liset J de la Fonteyne-Blankestijn
EGEric R Gremmer
Eric R Gremmer
HVHenny W Verharen
Henny W Verharen
WJWim De Jong
Wim De Jong
Nanosilver is used in a variety of medical and consumer products because of its antibacterial activity. This wide application results in an increased human exposure. Knowledge on the systemic toxicity of nanosilver is, however, relatively scarce. In a previous study, the systemic toxicity of 20 nm silver nanoparticles (Ag-NP) was studied in a 28-day repeated-dose toxicity study in rats. Ag-NP were intravenously administered with a maximum dose of 6 mg/kg body weight (bw)/day. Several immune parameters were affected: reduced thymus weight, increased spleen weight and spleen cell number, a strongly reduced NK cell activity, and reduced IFN-γ production were observed.

1 January 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
MBManon C. Bouwmeester
Manon C. Bouwmeester
SRSander Ruiter
Sander Ruiter
TLTobias Lommelaars
Tobias Lommelaars
JSJosefine Sippel
Josefine Sippel
HHHennie M. Hodemaekers
Hennie M. Hodemaekers
LVLeo TM van der Ven
Leo TM van der Ven